The core of Agenus’ operations revolves around harnessing the strength of the immune procedure to focus on and handle challenging-to-handle cancers and infections. The company’s product candidates are meant to teach and activate immune responses by precisely targeting most cancers cells, thereby offering opportunity new avenues from the remedy